| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Proteins | 14 | 2015 | 1901 | 1.130 |
Why?
|
| Loss of Heterozygosity | 12 | 2013 | 623 | 1.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 14 | 2000 | 413 | 1.020 |
Why?
|
| Membrane Proteins | 14 | 2007 | 2922 | 0.900 |
Why?
|
| Metagenome | 2 | 2012 | 192 | 0.740 |
Why?
|
| Genes, Tumor Suppressor | 10 | 2005 | 1127 | 0.640 |
Why?
|
| Chromosomes, Human, Pair 18 | 5 | 2003 | 190 | 0.610 |
Why?
|
| Bacteria | 2 | 2012 | 650 | 0.580 |
Why?
|
| Microfilament Proteins | 14 | 2007 | 491 | 0.520 |
Why?
|
| Callithrix | 1 | 2014 | 18 | 0.480 |
Why?
|
| Metagenomics | 2 | 2012 | 122 | 0.470 |
Why?
|
| Genome | 2 | 2014 | 689 | 0.450 |
Why?
|
| Genetic Markers | 10 | 2004 | 1073 | 0.450 |
Why?
|
| Gene Deletion | 8 | 2013 | 1471 | 0.430 |
Why?
|
| Alleles | 8 | 2012 | 2598 | 0.410 |
Why?
|
| Breast Neoplasms | 21 | 2009 | 16244 | 0.400 |
Why?
|
| Health | 1 | 2012 | 51 | 0.400 |
Why?
|
| Biodiversity | 1 | 2012 | 95 | 0.390 |
Why?
|
| Sequence Analysis, DNA | 11 | 2015 | 2560 | 0.380 |
Why?
|
| Wilms Tumor | 5 | 1996 | 301 | 0.380 |
Why?
|
| Cytoskeletal Proteins | 4 | 2004 | 526 | 0.360 |
Why?
|
| Beckwith-Wiedemann Syndrome | 4 | 1996 | 39 | 0.350 |
Why?
|
| Exome | 6 | 2013 | 1249 | 0.310 |
Why?
|
| Chromosome Deletion | 4 | 2003 | 1057 | 0.300 |
Why?
|
| Genes, Wilms Tumor | 3 | 1996 | 62 | 0.280 |
Why?
|
| Meningioma | 4 | 2003 | 308 | 0.270 |
Why?
|
| Exons | 5 | 2012 | 1388 | 0.260 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2005 | 220 | 0.260 |
Why?
|
| Genomics | 4 | 2015 | 2832 | 0.250 |
Why?
|
| Protein Methyltransferases | 1 | 2005 | 46 | 0.250 |
Why?
|
| Meningeal Neoplasms | 4 | 2003 | 473 | 0.240 |
Why?
|
| Bees | 2 | 2015 | 32 | 0.240 |
Why?
|
| Colonic Neoplasms | 2 | 2012 | 1435 | 0.230 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 6639 | 0.230 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2002 | 89 | 0.230 |
Why?
|
| Genes, Insect | 2 | 2015 | 143 | 0.230 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1240 | 0.230 |
Why?
|
| Introns | 4 | 2015 | 460 | 0.220 |
Why?
|
| Genetic Heterogeneity | 2 | 2002 | 338 | 0.210 |
Why?
|
| Neuropeptides | 2 | 2000 | 162 | 0.200 |
Why?
|
| Microsatellite Repeats | 3 | 2003 | 627 | 0.200 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 87 | 0.200 |
Why?
|
| Translocation, Genetic | 4 | 1996 | 1286 | 0.200 |
Why?
|
| Carcinoma | 3 | 2011 | 2610 | 0.200 |
Why?
|
| Nevus, Pigmented | 1 | 2002 | 117 | 0.190 |
Why?
|
| Brain Neoplasms | 5 | 2003 | 4968 | 0.190 |
Why?
|
| Chromosome Mapping | 10 | 2015 | 1648 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2002 | 298 | 0.190 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1996 | 273 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 3 | 1996 | 342 | 0.190 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 596 | 0.190 |
Why?
|
| Blood Proteins | 1 | 2002 | 297 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 354 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2015 | 4644 | 0.180 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 2347 | 0.170 |
Why?
|
| Kidney Neoplasms | 5 | 1996 | 3107 | 0.170 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2012 | 509 | 0.170 |
Why?
|
| Apoptosis | 4 | 2009 | 7755 | 0.160 |
Why?
|
| Base Sequence | 9 | 2011 | 5405 | 0.160 |
Why?
|
| Mutation | 6 | 2012 | 15917 | 0.160 |
Why?
|
| Neurofibromin 2 | 4 | 2002 | 40 | 0.160 |
Why?
|
| Synteny | 2 | 2015 | 81 | 0.150 |
Why?
|
| Astrocytoma | 2 | 2001 | 325 | 0.150 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 1996 | 76 | 0.150 |
Why?
|
| Phosphoproteins | 2 | 2002 | 1126 | 0.150 |
Why?
|
| Open Reading Frames | 3 | 2015 | 275 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 10 | 2011 | 5759 | 0.140 |
Why?
|
| Humans | 57 | 2015 | 270713 | 0.140 |
Why?
|
| Carcinoma in Situ | 1 | 2001 | 489 | 0.140 |
Why?
|
| Autophagy | 3 | 2009 | 905 | 0.140 |
Why?
|
| DNA, Neoplasm | 8 | 2004 | 1958 | 0.140 |
Why?
|
| DNA Methylation | 5 | 2014 | 2768 | 0.140 |
Why?
|
| Cellular Senescence | 3 | 2009 | 389 | 0.130 |
Why?
|
| Evolution, Molecular | 3 | 2015 | 866 | 0.130 |
Why?
|
| Proteins | 1 | 2004 | 2030 | 0.130 |
Why?
|
| Female | 31 | 2015 | 148885 | 0.130 |
Why?
|
| DNA Probes | 3 | 1995 | 244 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4809 | 0.120 |
Why?
|
| Phylogeny | 2 | 2014 | 854 | 0.120 |
Why?
|
| Arthropods | 1 | 2014 | 25 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 8 | 2003 | 3464 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 4532 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2001 | 1235 | 0.120 |
Why?
|
| Mutation Rate | 2 | 2012 | 220 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2015 | 9048 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2006 | 3568 | 0.120 |
Why?
|
| Lung Neoplasms | 8 | 2004 | 12039 | 0.110 |
Why?
|
| Methylation | 2 | 2006 | 625 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1995 | 257 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1994 | 183 | 0.110 |
Why?
|
| Sequence Tagged Sites | 1 | 1993 | 43 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2003 | 142 | 0.110 |
Why?
|
| Social Behavior | 1 | 2015 | 308 | 0.110 |
Why?
|
| Caspase 3 | 4 | 2007 | 460 | 0.110 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2004 | 192 | 0.100 |
Why?
|
| Cell Line, Tumor | 8 | 2015 | 14878 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2011 | 19 | 0.100 |
Why?
|
| Reproduction | 1 | 2014 | 277 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2000 | 1778 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2006 | 1801 | 0.100 |
Why?
|
| Consensus Sequence | 1 | 2011 | 117 | 0.100 |
Why?
|
| Ecosystem | 1 | 2012 | 115 | 0.100 |
Why?
|
| Demography | 1 | 2013 | 432 | 0.100 |
Why?
|
| Aging | 3 | 2014 | 1531 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2015 | 752 | 0.100 |
Why?
|
| Polymorphism, Genetic | 5 | 2014 | 1557 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 4899 | 0.090 |
Why?
|
| Malformations of Cortical Development | 1 | 2011 | 59 | 0.090 |
Why?
|
| Reference Standards | 1 | 2012 | 369 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2012 | 448 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 188 | 0.090 |
Why?
|
| Melanoma | 2 | 2011 | 5599 | 0.090 |
Why?
|
| Glioma | 1 | 2002 | 1986 | 0.090 |
Why?
|
| Protein Binding | 3 | 2015 | 3472 | 0.090 |
Why?
|
| Ependymoma | 2 | 2003 | 264 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 341 | 0.090 |
Why?
|
| Base Pairing | 1 | 2010 | 68 | 0.090 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 83 | 0.090 |
Why?
|
| Patient Care | 1 | 2011 | 148 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 380 | 0.090 |
Why?
|
| Gene Frequency | 6 | 2011 | 1246 | 0.090 |
Why?
|
| Hybrid Cells | 3 | 1996 | 148 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 5145 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 116 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2014 | 2882 | 0.080 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 617 | 0.080 |
Why?
|
| Heterozygote | 5 | 2011 | 1057 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 557 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2004 | 5582 | 0.080 |
Why?
|
| DNA, Satellite | 2 | 2001 | 44 | 0.080 |
Why?
|
| Animals | 12 | 2015 | 61357 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2012 | 352 | 0.080 |
Why?
|
| Adult | 14 | 2014 | 82041 | 0.080 |
Why?
|
| Phenotype | 5 | 2012 | 6502 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 1581 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2011 | 822 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 722 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 1469 | 0.080 |
Why?
|
| Male | 19 | 2015 | 128479 | 0.070 |
Why?
|
| Polyploidy | 1 | 2007 | 76 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1994 | 930 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 1004 | 0.070 |
Why?
|
| Calcitriol | 1 | 2006 | 135 | 0.070 |
Why?
|
| Genome, Human | 2 | 2011 | 1896 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 840 | 0.070 |
Why?
|
| Genetic Variation | 4 | 2014 | 2157 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2007 | 286 | 0.070 |
Why?
|
| Adolescent | 7 | 2012 | 32689 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2006 | 146 | 0.060 |
Why?
|
| Selenoproteins | 2 | 2015 | 15 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1576 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 1023 | 0.060 |
Why?
|
| S-Adenosylmethionine | 1 | 2004 | 43 | 0.060 |
Why?
|
| Interspersed Repetitive Sequences | 2 | 2015 | 35 | 0.060 |
Why?
|
| Cell Line | 3 | 2005 | 5313 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 3582 | 0.060 |
Why?
|
| Sequence Deletion | 3 | 2011 | 908 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2014 | 5415 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 579 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2007 | 1023 | 0.060 |
Why?
|
| Disease Progression | 4 | 2003 | 6881 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1581 | 0.060 |
Why?
|
| Alanine | 1 | 2004 | 243 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3345 | 0.050 |
Why?
|
| Young Adult | 2 | 2012 | 22243 | 0.050 |
Why?
|
| Pyrroles | 1 | 2007 | 588 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2006 | 639 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2004 | 198 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 390 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 142 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2011 | 6344 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 174 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 651 | 0.050 |
Why?
|
| Chromosome Aberrations | 3 | 2007 | 2035 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1407 | 0.050 |
Why?
|
| Genes, p16 | 1 | 2002 | 132 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 4992 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 672 | 0.050 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 1995 | 296 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2002 | 101 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 437 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 5777 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2002 | 141 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 618 | 0.050 |
Why?
|
| Cricetinae | 2 | 1994 | 744 | 0.050 |
Why?
|
| Neurofibromatosis 2 | 1 | 2001 | 33 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2009 | 3145 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2015 | 758 | 0.050 |
Why?
|
| Methotrexate | 1 | 2004 | 1025 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2002 | 155 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 2249 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 656 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 886 | 0.040 |
Why?
|
| Cell Division | 2 | 2002 | 2657 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1188 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2000 | 82 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 843 | 0.040 |
Why?
|
| Prognosis | 5 | 2003 | 22528 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 205 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2003 | 5332 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 1093 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2000 | 136 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 2986 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2013 | 6233 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 1111 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1381 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 2356 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 5869 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2004 | 7648 | 0.040 |
Why?
|
| Colon | 2 | 2004 | 684 | 0.040 |
Why?
|
| Transfection | 1 | 2002 | 3109 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 469 | 0.030 |
Why?
|
| Aged | 6 | 2014 | 73613 | 0.030 |
Why?
|
| Child, Preschool | 7 | 2013 | 17072 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 14638 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 1072 | 0.030 |
Why?
|
| Kidney | 1 | 2005 | 2102 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1996 | 111 | 0.030 |
Why?
|
| Middle Aged | 7 | 2014 | 90533 | 0.030 |
Why?
|
| Pulmonary Blastoma | 1 | 1996 | 21 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 1491 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 420 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2006 | 3656 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2454 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 9 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 381 | 0.030 |
Why?
|
| Child | 8 | 2013 | 30560 | 0.030 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1995 | 45 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2003 | 10404 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2015 | 113 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
| Receptors, Odorant | 1 | 2014 | 47 | 0.030 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 44 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 1944 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 125 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2014 | 40 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 1995 | 106 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2000 | 1610 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1995 | 197 | 0.030 |
Why?
|
| Registries | 1 | 2002 | 2210 | 0.030 |
Why?
|
| Base Composition | 1 | 2014 | 92 | 0.030 |
Why?
|
| Pedigree | 3 | 2011 | 2040 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1994 | 134 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 783 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 5157 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 727 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 547 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 888 | 0.030 |
Why?
|
| Population Control | 1 | 2013 | 5 | 0.030 |
Why?
|
| CHO Cells | 1 | 1994 | 320 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 284 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 196 | 0.030 |
Why?
|
| Multigene Family | 1 | 2014 | 469 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 242 | 0.030 |
Why?
|
| Chromosomes, Insect | 1 | 2012 | 8 | 0.030 |
Why?
|
| Lymphocytes | 3 | 2003 | 1273 | 0.030 |
Why?
|
| Starvation | 1 | 2012 | 24 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2012 | 86 | 0.030 |
Why?
|
| Centromere | 1 | 2012 | 138 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2015 | 1683 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2013 | 202 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 494 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 49 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2011 | 413 | 0.020 |
Why?
|
| Rats | 1 | 2000 | 6397 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2012 | 163 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2015 | 1825 | 0.020 |
Why?
|
| Globins | 1 | 1991 | 80 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 151 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 809 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2012 | 196 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 94 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 1458 | 0.020 |
Why?
|
| Family Health | 1 | 2012 | 347 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 1381 | 0.020 |
Why?
|
| Cricetulus | 1 | 1991 | 214 | 0.020 |
Why?
|
| X Chromosome | 1 | 2012 | 400 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 233 | 0.020 |
Why?
|
| Oncogenes | 1 | 1994 | 697 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2014 | 889 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 109 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 771 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2014 | 9463 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 674 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2007 | 7232 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 1175 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 319 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2011 | 502 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 251 | 0.020 |
Why?
|
| Genotype | 2 | 2012 | 4248 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 3205 | 0.020 |
Why?
|
| Mice | 3 | 2005 | 35421 | 0.020 |
Why?
|
| Gene Library | 1 | 2010 | 351 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 546 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 866 | 0.020 |
Why?
|
| Peptides | 1 | 2014 | 1503 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 12978 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 1161 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 908 | 0.020 |
Why?
|
| DNA Damage | 2 | 2006 | 1991 | 0.020 |
Why?
|
| Cell Adhesion Molecule-1 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2002 | 13419 | 0.020 |
Why?
|
| Sulfites | 1 | 2007 | 45 | 0.020 |
Why?
|
| United States | 2 | 2002 | 15828 | 0.020 |
Why?
|
| Free Radicals | 1 | 2006 | 62 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 1562 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1995 | 4966 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3929 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 527 | 0.020 |
Why?
|
| Microtubules | 1 | 2007 | 328 | 0.020 |
Why?
|
| Software | 1 | 2013 | 1357 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 2005 | 102 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 15275 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 1295 | 0.020 |
Why?
|
| Lung | 1 | 1996 | 3284 | 0.010 |
Why?
|
| G1 Phase | 1 | 2005 | 306 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 650 | 0.010 |
Why?
|
| Lactation | 1 | 2005 | 234 | 0.010 |
Why?
|
| Dinucleotide Repeats | 1 | 2003 | 12 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 564 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 4105 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1995 | 9281 | 0.010 |
Why?
|
| Decision Making | 1 | 2011 | 1249 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 538 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 465 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2004 | 561 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2011 | 1692 | 0.010 |
Why?
|
| DNA Primers | 2 | 1996 | 1489 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 2004 | 205 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 2112 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 31116 | 0.010 |
Why?
|
| Lasers | 1 | 2003 | 235 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 2363 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 1058 | 0.010 |
Why?
|
| Contraindications | 1 | 2001 | 153 | 0.010 |
Why?
|
| Infant | 3 | 2003 | 13994 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 687 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1996 | 5604 | 0.010 |
Why?
|
| Azacitidine | 1 | 2007 | 1218 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 6193 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 1439 | 0.010 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1999 | 17 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1998 | 10726 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 79 | 0.010 |
Why?
|
| DNA Repair | 1 | 2006 | 1906 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 1874 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 1626 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 4907 | 0.010 |
Why?
|
| Dinucleoside Phosphates | 1 | 1996 | 25 | 0.010 |
Why?
|
| Bucladesine | 1 | 1996 | 32 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1996 | 15 | 0.010 |
Why?
|
| Colforsin | 1 | 1996 | 66 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 1996 | 23 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1996 | 28 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 1996 | 32 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 33847 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2312 | 0.010 |
Why?
|
| Butyrates | 1 | 1996 | 57 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 1996 | 120 | 0.010 |
Why?
|
| Japan | 1 | 1996 | 240 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 1000 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 1996 | 107 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 17861 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 238 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2005 | 2658 | 0.010 |
Why?
|
| Neoplasms | 2 | 2003 | 15949 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 7916 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1994 | 12 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 7052 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 92 | 0.010 |
Why?
|
| Karyotyping | 1 | 1996 | 1064 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1996 | 525 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5417 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1996 | 486 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 7916 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 9053 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 10268 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 1127 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1994 | 566 | 0.010 |
Why?
|
| Carcinoma, Lobular | 1 | 1994 | 622 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 4202 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12530 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 3707 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1996 | 2440 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 14033 | 0.000 |
Why?
|
| Leukemia | 1 | 1996 | 1719 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2005 | 12042 | 0.000 |
Why?
|
| Breast | 1 | 1993 | 1370 | 0.000 |
Why?
|
| Incidence | 1 | 1996 | 5825 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1996 | 4104 | 0.000 |
Why?
|
| DNA | 1 | 1993 | 3041 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2003 | 39959 | 0.000 |
Why?
|